BioSpace News Archive

The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at one of the premier meetings for radiation oncologists

DURECT Corporation (Nasdaq: DRRX) announced today that further development of a long-acting injectable HIV investigational product utilizing DURECT’s SABER® technology has triggered a $10 million milestone payment from Gilead Sciences, Inc. to DURECT under the license agreement between the companies.

Luke Gordon has been named the vice president of network development at EPIC Pharmacy Network, a nationwide Pharmacy Services Administration Organization for independent pharmacies.

Johnson & Johnson Services Inc., Stryker Corp., Wright Medical Group NV, and Zimmer Biomet Holdings Inc. are competing for a bigger share of the healthcare industry, including health care equipment & services market, backed by the increasing investments in R&D, constant innovations and new product launches.

Aetna, a CVS Health (NYSE: CVS) company, announced today that online voting is underway for the 2019 “Aetna Voices of Health” program at www.aetnavoicesofhealth.com.

As concerns about Americans’ exposure to a certain group of chemical substances continues to grow, Battelle researchers have added another tool in their suite to help assess and understand occurrence.

BEYOND / HELLO™, a premier retail chain owned by Jushi Holdings Inc. (“Jushi” or the “Company”)(NEO: JUSH.B), a leading company focused on bringing only the best, personalized marijuana treatments and products to customers, today announced BEYOND / HELLO has opened two additional retail locations

Vantage Solutions, the manufacturing efficiency experts, today announced it is supporting the Food and Drug Administration (FDA) Pilot for Verification Router Service (VRS) testing sponsored by rfxcel.

Astute, trusted by the world’s most innovative brands to deliver better customer engagement, today announced the addition of Phil Hoey and Dave Butler to their executive team.